If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.40b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
Β 

Jardine Matheson Holdings Limited

Directorate Change

Β 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

Β 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

Β 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

Β 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

Β 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

Β 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

Β 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

Β 

- end -

Β 

For further information please contact

Β 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

Β 

(852) 2843 8223

Β 

Media enquiries:

Brunswick

Tom Burns

Β 

(44) 207 404 5959

David Ashton

(852) 3512 5063

Β 

This and other Group announcements can be accessed at www.jardines.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAUPUBAWUPUURA
Date   Source Headline
17th Oct 202511:18 amRNSDirector/PDMR Shareholding
17th Oct 202510:26 amRNSRecommended Cash Acquisition of Mandarin Oriental
17th Oct 202510:24 amRNSRecommended Cash Acquisition of Mandarin Oriental
17th Oct 202510:21 amRNSSale of 301,555 sq.ft. of One Causeway Bay
9th Oct 202510:37 amRNSAdditional Listing
2nd Oct 202510:23 amRNSDividend
30th Sep 202510:27 amRNSTotal Voting Rights
26th Sep 202511:52 amRNSDividend
25th Sep 202510:48 amRNSBlock listing Interim Review
9th Sep 202511:04 amRNSDirector/PDMR Shareholding
4th Sep 202510:45 amRNSDirector/PDMR Shareholding
3rd Sep 202510:21 amRNSCirc re. Scrip Dividend Scheme
11th Aug 202511:01 amRNSDirector/PDMR Shareholding
8th Aug 202510:18 amRNSDirector/PDMR Shareholding
31st Jul 202512:04 pmRNSHalf-year Results
31st Jul 202511:10 amRNSPT DFI RETAIL NUSANTARA TBK HALF YEAR 2025 RESULTS
30th Jul 202512:30 pmRNSJC&C 2025 Half-Year Results
30th Jul 202512:10 pmRNSPT Astra 2025 First Half Financial Statements
29th Jul 202511:13 amRNSHalf-year Results
28th Jul 202512:33 pmRNSHalf-year Results
11th Jul 202510:26 amRNSNotification to Untraced Shareholders
2nd Jul 202510:38 amRNSDirector/PDMR Shareholding
30th Jun 202512:19 pmRNSExtractive Sector: Payments to Govts Report 2024
30th Jun 202510:27 amRNSDirector/PDMR Shareholding
27th Jun 202511:21 amRNSDirector/PDMR Shareholding
24th Jun 202510:38 amRNSDirector/PDMR Shareholding
13th Jun 202510:32 amRNSDirector/PDMR Shareholding
3rd Jun 202510:20 amRNSDirector/PDMR Shareholding
30th May 202510:23 amRNSTotal Voting Rights
29th May 202510:23 amRNSDirectorate Change
23rd May 202511:27 amRNSInterim Management Statement
23rd May 202511:01 amRNSBoard Changes
22nd May 202511:19 amRNSINTERIM MANAGEMENT STATEMENT
21st May 202510:26 amRNSDirector/PDMR Shareholding
19th May 202511:23 amRNSINTERIM MANAGEMENT STATEMENT
16th May 202510:33 amRNSDirector/PDMR Shareholding
15th May 202511:44 amRNSINTERIM MANAGEMENT STATEMENT
14th May 202511:03 amRNSTotal Voting Rights
8th May 202510:48 amRNSAdditional Listing
2nd May 20251:00 pmRNSResult of AGM
30th Apr 202512:24 pmRNSJC&C Interim Management Statement
30th Apr 202512:20 pmRNSPT Astra 2025 First Quarter Financial Statements
30th Apr 202510:58 amRNSPT DFI Retail Nusantara Tbk 3 Months 2025 Results
30th Apr 202510:31 amRNSDividend
25th Apr 202511:22 amRNSDividend
7th Apr 202510:22 amRNSAnnual Financial Report
2nd Apr 202510:31 amRNSCirc re. Scrip Dividend Scheme
28th Mar 20259:53 amRNSDirector/PDMR Shareholding
25th Mar 20259:48 amRNSBlock listing Interim Review
17th Mar 20259:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.